|
Ranbaxy Pharmaceuticals, Inc. (RPI) is in a real no-name business. The company, the US arm of Indian generic pharmaceuticals giant Ranbaxy Laboratories Limited, makes and markets about 50 generic and over-the-counter (OTC) drugs. It accounts for about a quarter of its parent's annual revenues. RPI's generic offerings, produced by manufacturing subsidiary Ohm Laboratories, include anti-infectives and treatments for cardiovascular, gastrointestinal, and central nervous system disorders. Its OTC products include analgesics, antihistamines, and decongestants. Sister subsidiary Ranbaxy Laboratories, Inc. (RLI) develops branded pharmaceuticals.
|
| | | Contact Information | |
Address: |
600 College Rd. East, Ste. 2100
Princeton, NJ 08540
| | Phone: | 609-720-9200 | | Fax: | 609-720-1155 |
|
|
Key People
| | • |
VP and Regional Director, North America:
Venkatachalam (Venkat) Krishnan
| | • |
VP and CFO:
Lalit Ahluwalia
| | • |
VP Business Development, North America:
Joseph Todisco
|
|
|
